Journal
ENVIRONMENTAL CHEMISTRY LETTERS
Volume 17, Issue 4, Pages 1565-1583Publisher
SPRINGER HEIDELBERG
DOI: 10.1007/s10311-019-00897-7
Keywords
Polymeric nanoparticles; Lung cancer; Micelles; Drug delivery systems
Ask authors/readers for more resources
Research has recently focused on combinational therapy using nanocarriers to overcome the obstacles associated with conventional therapy of lung cancer. The classical therapeutic approach is indeed insufficient for suppressing tumor growth. Simultaneous delivery improves therapeutic outcomes, synergistic effects, and targeting moiety. Besides, multidrug-loaded nanocarriers allows the consecutive release of two or more drugs and genes. A such nanodrug delivery system reduces drug-drug interactions and improves the pharmacokinetics profile of loaded drugs. Currently, nanotechnology-based co-delivery system is the only suitable option for lung cancer therapy. Combinational delivery systems show promising results for the treatment of lung cancer. Here we review the design and development of co-delivery systems based on nanocarriers for effective cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available